Blood-based biomarker screening with agnostic biological definitions for an accurate diagnosis within the dimensional spectrum of neurodegenerative diseases

for the Alzheimer Precision Medicine Initiative (APMI)

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Blood-based biomarker screening with agnostic biological definitions for an accurate diagnosis within the dimensional spectrum of neurodegenerative diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences